MOSS — Moss Genomics Income Statement
0.000.00%
Last trade - 00:00- CA$3.46m
- -CA$0.06m
- 45
- 73
- 32
- 49
Annual income statement for Moss Genomics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 0.108 | 0.655 | 0.73 | 0.133 | 0.419 |
| Operating Profit | -0.108 | -0.655 | -0.73 | -0.133 | -0.419 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.108 | -0.655 | -0.73 | -0.133 | -0.676 |
| Net Income After Taxes | -0.108 | -0.655 | -0.73 | -0.133 | -0.676 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.108 | -0.655 | -0.73 | -0.133 | -0.676 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.108 | -0.655 | -0.73 | -0.133 | -0.676 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.015 | -0.016 | -0.003 | -0.014 |
| Dividends per Share |